Roundup and analysis of the top headlines on health security, pandemic preparedness, COVID-19, and other news from the Johns Hopkins Center for Health Security


Please note that some links may require subscription or registration.

September 19, 2024



NOTICE: Health Security Decoded will not be published next week. We will be back on October 3.

TOP NEWS

As mpox outbreak grows in Africa, WHO prequalifies vaccine, Gavi pledges 500K doses, Africa CDC calls on wealthy nations to step up response to ‘rebuild trust’


The Africa CDC today reported a “worrying” increase in mpox virus cases on the continent, with 2,912 new cases and 14 deaths recorded in the past week (Epi week 36). Last week, the agency reported a significant increase in mpox-related deaths, with 107 new fatalities recorded in the previous week (Epi week 35). This brings the total number of cases to more than 29,150 (6,105 confirmed) and associated deaths to 738 for the year. Fifteen (15) African Union member states across all 5 regions of the continent have reported cases. Dr. Jean Kaseya, the agency’s director-general, called the rising toll “too much” and “not acceptable” and noted that children under age 15 are “disproportionately affected.” The Democratic Republic of the Congo (DRC) is the most affected country, with the mining town of Kamituga in South Kivu province being the epicenter of the outbreak.


WHO prequalifies mpox vaccine

Last week, WHO prequalified Bavarian Nordic’s MVA-BN vaccine (also known as Jynneos, Imvanex, and Imvamune), making it the first mpox vaccine to receive such a listing. Prequalification will facilitate the procurement and distribution of the vaccine by organizations such as Gavi and UNICEF, particularly in those low- and middle-income countries that cannot afford to purchase supplies. WHO recommended that single doses be given in supply-constrained areas instead of the usual 2-dose regimen. The agency also permitted “off-label” use for infants, children, and adolescents, as the vaccine is not yet authorized for individuals under age 18 years, as well as for pregnant and immunocompromised people, if the benefits outweigh risks.


Africa CDC calls on wealthy nations

Questions remain over whether the estimated 18 million to 22 million doses needed to vaccinate 10 million people over the next 6 months will reach areas in need. DRC has received only 250,000 doses from the EU and US. Japan this week announced it will donate 3 million doses of KM Biologics’ LC16 mpox vaccine to DRC. Unlike MVA-BN, LC16 is authorized for use in children. Notably, however, health workers will need special training to administer the vaccine, which is done by intradermal scraping. DRC is expected to begin vaccinations in early October, and Rwanda, which has received 1,000 vaccine doses, began its campaign this week. Dr. Kaseya called on wealthy nations to implement lessons they learned during the COVID-19 pandemic and donate vaccine doses to “rebuild the trust.” He said he is confident Africa CDC can raise US$600 million needed to fight the growing outbreak.


Gavi to supply vaccine doses

Bolstering the sentiment on lessons learned, Gavi, the Vaccine Alliance CEO Dr. Sania Nishtar said the COVID pandemic resulted in specific instruments that are now being used against mpox. Gavi announced this week it has signed an agreement with Bavarian Nordic to supply 500,000 doses of MVA-BN vaccine to countries in Africa affected by the outbreak. With up to US$50 million in full costs—including transportation, delivery, and administration—funded through Gavi’s new First Response Fund, the doses are expected to be delivered this year. Additionally, the Global Fund to Fight AIDS, Tuberculosis and Malaria said this week it will support DRC with US$9.5 million for its emergency mpox response. UNICEF this week launched an appeal for US$58.8 million to address the mpox emergency in 6 African nations where children are most affected.


US response

Leaders from the US National Security Council and the White House Office of Pandemic Preparedness and Response Policy this week held a roundtable discussion with federal agencies, global and domestic public health partners, advocacy groups, and community leaders to discuss the mpox outbreaks in DRC and other countries that have never recorded cases. US officials confirmed they are committed to bringing the outbreak under control and ensuring it does not develop into a pandemic. Health officials from the US HHS and CDC last night participated in a panel discussion on the mpox emergency hosted by the Capitol Hill Steering Committee on Pandemic Preparedness & Health Security, which is sponsored and managed by the Johns Hopkins Center for Health Security (see more below). Additionally, as part of the US response, NIH released an update on its priorities for mpox research.


Opinion pieces

Several publications have recently published opinion pieces and commentaries on the mpox emergency and response, including the following:

STAT: WHO pandemic threat director: Here’s what needs to happen to combat mpox (opinion)

EU Observer: Mpox is now a litmus test for EU's health-crisis management (opinion)

Los Angeles Times: Opinion: Will we let mpox spread, repeating devastating public health failures? (opinion)

Washington Post: The Checkup With Dr. Wen: It’s not too late for Americans to get the mpox vaccine (opinion)

The Lancet: Mpox and breastmilk: for once, can we act in time? (correspondence)

MORE HEADLINES

As US enters flu season, some experts worry about potential for reassortment between avian and human flu viruses

MIT Technology Review: Why virologists are getting increasingly nervous about bird flu

CNN: The US is entering a riskier season for spread of H5N1 bird flu. Here’s why experts are worried

Slate: Just How Deadly Is Bird Flu to Humans?


Close contact of Missouri human bird flu case experienced symptoms around same time but was not tested for influenza, raising more questions

New York Times: Missouri Bird Flu Case Raises Prospect of Human Transmission

STAT: Inquiry into unexplained bird flu case in Missouri broadens to a close contact

NBC News: CDC says close contact of Missouri bird flu patient showed symptoms

CIDRAP: Symptomatic contacts reported in probe into Missouri H5N1 flu case

See also: CNN: Mysterious bird flu case in Missouri was similar to strain circulating in cattle, CDC says


Massachusetts conducts testing for avian flu on 95 licensed dairy farms, finds no positive samples

Boston.com: Mass. dairy herds ‘100% negative’ for bird flu, agriculture officials say

Massachusetts Department of Agricultural Resources: State Officials Announce 100% Negative Results for HPAI Testing in Dairy Herds


Opinion pieces, blog post discuss US response to H5N1 bird flu outbreak

STAT: Q&A: The U.S. can, and should, do more on H5N1 bird flu, a top WHO official says

Think Global Health: The United States Isn't Ready for a Bird Flu Epidemic

Bulletin of the Atomic Scientists: Preventing the next pandemic should start with protecting farm workers


WHO member states resume pandemic agreement negotiations but language, PABS remain sticking points

Devex: Devex CheckUp: Pandemic negotiations resume — but jargon's getting in the way

Geneva Health Files: Slow Progress as Schism Continues Between Countries [Update: Pandemic Agreement Talks]

Health Policy Watch: New Pandemic ‘Lite’ Agreement Shifts Key Decisions to Post-Negotiation Forum

See also: CIDRAP: Global health experts note improved post-COVID pandemic preparedness, but large gaps remain


US NIH establishes pandemic preparedness research network to develop vaccines, monoclonal antibodies for high-priority pathogens

US National Institutes of Health: NIH awards establish pandemic preparedness research network

Fierce Biotech: NIH establishes pandemic preparedness network, plans up to $100M in yearly funding for work on new treatments and vaccines

See also: Pharmaceutical Technology: Into the unknown: How quickly can vaccines be developed for Disease X


The Center for Health Security this week published a new report focused on how communities can holistically and equitably recover from pandemics. Read it here: Recovery Metrics to Drive Equity (PanREMEDY): Guidelines for State and Local Leaders in Anticipation of Future Catastrophic Outbreaks


Wastewater, other pathogen surveillance methods vital for pandemic preparedness, prevention, National Academies report, viewpoint article say

CIDRAP: National Academies: Wastewater surveillance could be even better for detecting pathogens

Frontiers in Science: Thinking beyond pathogen surveillance: building resilient biotech ecosystems to combat the next pandemic


New OpenAI o1 model presents ‘medium risk’ for issues related to CBRN weapons, company says; some experts issue urgent call for legislation to regulate sector

Financial Times: OpenAI acknowledges new models increase risk of misuse to create bioweapons

Newsweek: OpenAI o1 Model Warning Issued by Scientist: 'Particularly Dangerous'

See also: Washington Post: Unprepared for the rising, nightmarish risk of biological warfare (opinion)


Antimicrobial resistance could lead to more than 39M deaths by 2050, study estimates; experts, others call for more action ahead of UNGA meeting

CNN: Superbug crisis could get worse, killing nearly 40 million people by 2050, study estimates

CIDRAP: IDSA, ESCMID call for 'robust action' on antimicrobial resistance ahead of UN meeting

CIDRAP: WHO calls on countries to address gender inequalities in antimicrobial resistance

Devex: The African Union crafts a continental position on AMR ahead of UNGA

Nature: Tackling antimicrobial resistance needs a tailored approach — four specialists weigh in

See also: The Atlantic: A Fix for Antibiotic Resistance Could Be Hiding in The Past


Newly published, updated research supports theory SARS-CoV-2 likely spilled over to humans from animals sold in Wuhan market, does not rule out other origins

NPR: New research points to raccoon dogs in Wuhan market as pandemic trigger. It's controversial

Washington Post: Scientists again link covid pandemic origin to Wuhan market animals

Newsweek: Scientists Shed Light on Wildlife Species at Origin of COVID-19 in Wuhan


KP.3.1.1 subvariant responsible for more than 50% of new US COVID cases; new XEC subvariant spreading fast globally

USA Today: This dominant COVID-19 variant accounts for over 50% of cases, new CDC data shows

The Telegraph: New XEC Covid variant spreading in the US, doctors warn

Axios: COVID wave ebbs in most states

Newsweek: US COVID-19 Rates Oscillate Every Six Months

See also: The Atlantic: Why Didn’t Facing a Common Enemy Bring Us Together? (opinion)


"The virus is always going to be mutating away from what it was in order to get more efficient at infecting individuals. … So, I think this really highlights the fact that a universal COVID vaccine, or some vaccine with different technologies, perhaps a nasal vaccine and using mucosal immunity, all of those things are important." – Dr. Amesh Adalja, Senior Scholar with the Center for Health Security, speaking with MedPage Today


Several studies, survey examine willingness, reluctance to receive vaccinations against COVID, flu

CIDRAP: 3 studies uncover flu, COVID vaccine reluctance, impact of mental illness on uptake

The Guardian: Only half of Americans plan to get Covid or flu vaccinations this year – study

npj Vaccines: COVID-19 vaccine refusal is driven by deliberate ignorance and cognitive distortions


Certain antivirals, metformin could cut risk of long COVID; research funding into new therapies faltering

CIDRAP: Evidence growing for COVID antivirals to cut poor outcomes, long COVID, experts say

CIDRAP: Common diabetes drug linked to lower rate of long COVID

Chemical & Engineering News: R&D for long COVID is collapsing


US child flu deaths for 2023–24 season tie record, CDC notes, highlights need for vaccination

US CDC: Flu Deaths in Children Last Season Reach 199, Matching Record

CIDRAP: Child flu deaths last season matched US record high

USA Today: CDC: Flu deaths in children reach troubling highs amid drops in vaccinations

See also: WHO: WHO updates influenza care guidelines, includes recommendations for viruses with pandemic potential


Los Angeles County reports 3 locally acquired dengue cases in unprecedented cluster

AP: Los Angeles area sees more dengue fever in people bitten by local mosquitoes

Los Angeles Times: ‘Unprecedented’ cluster of mosquito-borne dengue virus cases confirmed in Baldwin Park

See also: Nature: Mosquito-borne diseases are surging in Europe — how worried are scientists?


Wastewater surveillance detects increase in EV-D68, respiratory virus that can paralyze children

NBC: Virus that causes paralyzing illness is spiking in the U.S., wastewater data shows

Denver Post: A mysterious syndrome that paralyzed kids seems to have disappeared. But why?


Just as first round of polio vaccination campaign wraps up in Gaza, Pakistan capital city reports first case in 16 years, Taliban suspend Afghanistan’s campaign

Time: The First Round of the Gaza Polio Vaccine Campaign Is Complete. The Next Step Will Be Just as Hard

New York Times: Pakistan Seemed Close to Beating Polio. Now It’s Spreading Quickly.

Reuters: Two killed in attack on Pakistani polio vaccination team

AP: The Taliban have suspended polio vaccination campaigns in Afghanistan, the UN says


AI chatbot called DebunkBot successful in changing people’s beliefs in unfounded conspiracy theories

Financial Times: Chats with AI bots found to damp conspiracy theory beliefs

Nature: AI chatbot gets conspiracy theorists to question their convictions

New York Times: This Chatbot Pulls People Away From Conspiracy Theories


Number of imported US Oropouche virus cases reaches 74 in 5 states, most in Florida; study examines origin, genetic evolution of virus in current outbreak

CIDRAP: Imported Oropouche virus cases continue steady US rise

Nature Medicine: Human outbreaks of a novel reassortant Oropouche virus in the Brazilian Amazon region


Indian state of Kerala records second death from Nipah virus since July; 151 people being monitored

Times of India: Student dies of Nipah virus in Kerala: Why it is important to be very cautious

Reuters: One dead from Nipah virus in India's Kerala; second death this year


Emergent BioSolutions receives BARDA award option for US$41.9M to continue development of monoclonal antibody treatment for Ebola

CIDRAP: Emergent BioSolutions awarded BARDA contract for Ebola treatment

Precision Vaccinations: $41.9 Million Scales Up Ebola Treatments


Boar’s Head closes plant linked to listeria outbreak; survivors discuss health impacts of infection

AP: Boar’s Head closing Virginia plant linked to deadly listeria outbreak

New York Times: Violent Convulsions and Lost Speech: Listeria Survivors Describe Harrowing Illnesses


Global Fund Results Report outlines significant progress against HIV, TB, malaria, highlights challenges presented by climate change, conflict

Health Policy Watch: Big Wins – And Challenges – For Global Fund in Tackling HIV, TB and Malaria

Medical Xpress: Conflict, climate threaten fight against diseases: Fund


Injectable antiviral 96% effective in preventing HIV but could remain too expensive for many in need

NPR Goats and Soda: This preventive drug could be a 'game changer' in ending the HIV epidemic

NBC News: An injectable HIV-prevention drug is highly effective — but wildly expensive

STAT: Tested in Africa, used in America: How can we end the practice of HIV wonder drug experimentation in Africa? (opinion)

STAT: Medicaid must prepare to cover twice-yearly HIV prevention injection (opinion)

FROM THE CENTER

CHSC September 18 2024 panel photo
CHSC September 18 2024 panel view

Capitol Hill Steering Committee event discusses current mpox emergency, Congress’s role in responding


The Capitol Hill Steering Committee on Pandemic Preparedness & Health Security on September 18 held an event titled, The Current Mpox Crisis and Congress’s Role in Protecting the US from Health Security Threats. The panel discussion, moderated by Johns Hopkins Center for Health Security Director Dr. Tom Inglesby, examined the current global mpox outbreak and the US government’s response in cooperation with industry and academic partners. Participants in the panel included Phyllis Arthur, Executive Vice President & Head of Healthcare Policy & Programs, BIO; Loyce Pace, Assistant Secretary for Global Affairs, US Department of Health and Human Services; Dr. Athalia Christie, Associate Director for Emergency Preparedness and Response, US CDC; and Dr. Caitlin Rivers, Senior Scholar and Associate Professor, Johns Hopkins Center for Health Security, and Director, Center for Outbreak Response Innovation (CORI).


The Capitol Hill Steering Committee, which is sponsored and managed by the Center for Health Security, is an educational forum to discuss new topics, technologies, and ideas that can improve domestic health security now and in the future. For more information on last night’s event and previous sessions, visit https://centerforhealthsecurity.org/our-work/the-capitol-hill-steering-committee.

Editor: Alyson Browett, MPH

Contributing Editor: Prarthana Vasudevan, MS, MSPH, DrPH (c)

Give Today
Click to Subscribe
 
X  Youtube  Linkedin